31 January 2014 - Deborah Wilkes
Archived
Different or unconventional structures are on the agenda as Novartis reviews all the strategic options for its global OTC business and two other smaller businesses.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.